Results 181 to 190 of about 392,718 (341)
Editorial: Cardiovascular comorbidities in inflammatory rheumatic diseases. [PDF]
Triantafyllias K, Colina M, Misra DP.
europepmc +1 more source
Assessment of autoimmune rheumatic diseases activity during pregnancy [PDF]
Mai Omar Abdelaziz +3 more
openalex +1 more source
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation‐associated gene 5 antibody (MDA5 ab) associated dermatomyositis (DM). Methods Thirty patients with MDA5 ab DM were identified in a single center longitudinal cohort of 352 patients with ...
Jenice X Cheah +8 more
wiley +1 more source
Association between bruxism and inflammatory rheumatic diseases: is there a possible bidirectional relationship? [PDF]
Korkosz-Wróbel Z +3 more
europepmc +1 more source
Targeting the CXCL12/CXCR4 pathway by an optimized derivative or EPI-X4 preserves chondrocyte function and offers a novel therapeutic approach in rheumatic diseases [PDF]
Leonie Ruths +7 more
openalex +1 more source
Retractions in rheumatology: trends, causes, and implications for research integrity
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley +1 more source
Adenomyosis in patients with rheumatic diseases: a cross-disciplinary clinical observation. [PDF]
Vannuccini S +6 more
europepmc +1 more source
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
Bathon, J. +16 more
core +1 more source
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD) Methods PrismRA incorporated 19 gene expression features and 4 clinical features to assess a patient's likelihood of ...
Fenglong Xie +3 more
wiley +1 more source

